MicroPort CardioFlow Medtech Corporation (2160.HK) HKSE

1.23

-0.06(-4.65%)

Updated at October 17 04:08PM

Currency In HKD

Valuation

Market Cap1.49B
Enterprise Value1.46B
P/E Ratio541.83
PEG Ratio4.93
Price/Sales Ratio7.4
Price/Book Ratio1.2
Enterprise/Revenue7.26
Enterprise/EBITDA-30.39

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.01
Operating Margin-0.08

Management Effectiveness

Return On Assets0
Return On Equity0

Income Statement

Revenue361.57M
Revenue/Share0.16
Gross Profit251.21M
EBITDA-113.32M
Net Income-49.45M
Diluted EPS-0.02

Balance Sheet

Total Cash1.32B
Total Cash/Share0.57
Total Debt279.62M
Total Debt/Equity0.13
Current Ratio6.94
Book Value Per Share0.95

Price History

52-Week Change64
52-Week High1.69
52-Week Low0.63
Moving Average 50 Days1.41
Moving Average 200 Days1.05

Statistics

Average Volume12.76M
Shares Outstanding2.41B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A